Navio
Stefan J. Scherer M.D., Ph.D. is an accomplished executive and medical professional currently serving as the Chief Executive Officer of 3T Biosciences since July 2021 and as an External Advisory Committee Member for the University of Southern California Center for Cancer Drug Development. With extensive experience in the biotechnology and pharmaceutical sectors, Stefan has held influential roles including Board Member at Makucell Inc and prior positions such as Global Head of Experimental Medicine at GSK and Chief Medical Officer at Biocartis. Educational credentials include a Medical Doctor degree from the University of Freiburg and a Ph.D. in Physiological Chemistry from The Julius Maximilians University of Würzburg, complemented by additional qualifications in Bioinformatics from Heidelberg University.
This person is not in any teams
This person is not in any offices
Navio
1 followers
Navio is changing the narrative around cancer. Healthcare providers - get early access to treatment timelines that can save you time and improve patient experience. Patients - get Navio’s free app for patients and caregivers to manage treatment for malignant brain tumors.